Gjumrakch Aliev, MD & PhD has completed his PhD at the age of 29 years from Moscow State University and Institute of Human Morphology, Russian Academy of Medical Sciences, and Postdoctoral studies from University College of London, United Kingdom (advisor, Professor Geoffrey Burnstock). He is the President and CEO of “GALLY” International Biomedical Research Consulting LLC, San Antonio, TX, USA a premier Biomedical Research service organization. He also serves as a Professor of Cardiovascular Neuropathology, Geriatrics and Health Sciences and Healthcare Administration at the University of Atlanta, GA, USA. He has published more than 200 papers in reputed journals and serving as an Editors in Chief and Editorial Board Member of repute (more than 100). He is one of highly cited authors for his study the involvement of the mitochondria as a primary target in human diseases. Gjumrakch Aliev, MD & PhD has completed his PhD at the age of 29 years from Moscow State University and Institute of Human Morphology, Russian Academy of Medical Sciences, and Postdoctoral studies from University College of London, United Kingdom (advisor, Professor Geoffrey Burnstock). He is the President and CEO of “GALLY” International Biomedical Research Consulting LLC, San Antonio, TX, USA a premier Biomedical Research service organization. He also serves as a Professor of Cardiovascular Neuropathology, Geriatrics and Health Sciences and Healthcare Administration at the University of Atlanta, GA, USA. He has published more than 200 papers in reputed journals and serving as an Editors in Chief and Editorial Board Member of repute (more than 100). He is one of highly cited authors for his study the involvement of the mitochondria as a primary target in human diseases.

Surgery and Medicine